Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Lantheus Holdings, Inc. securities between February 26, 2025, and August 5, 2025, due to alleged misleading statements regarding the company's competitive position and pricing strategy for its product Pylarify [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Lantheus provided overwhelmingly positive statements while concealing material adverse facts about its competitive position and pricing dynamics for Pylarify [5]. - The lawsuit alleges that Lantheus failed to disclose that its early 2025 price increase, despite prior price erosion, created opportunities for competitive pricing, which could negatively impact Pylarify's revenue and growth potential [5]. Group 2: Participation Information - Investors who purchased Lantheus securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Snap Inc. securities between April 29, 2025, and August 5, 2025, of the upcoming lead plaintiff deadline on October 20, 2025, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Snap securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lead plaintiff must file a motion with the Court by October 20, 2025, to represent other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Snap's management misled investors by presenting overly optimistic expectations regarding advertising revenue and growth, while downplaying existing execution issues [5]. - It is claimed that when the true situation was revealed, investors suffered damages due to the misleading information provided during the Class Period [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Luminar Technologies, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on September 22, 2025 [1] Group 1: Class Action Details - Investors who purchased Luminar securities between March 20, 2025, and May 14, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by September 22, 2025 [3] - Investors are encouraged to select qualified counsel with a successful track record in securities class actions [4] Group 2: Case Allegations - The lawsuit alleges that Luminar's executives made false and misleading statements and failed to disclose critical information regarding CEO Austin Russell's undisclosed conduct, which could lead to his removal [5] - The potential loss of Russell could adversely affect Luminar's business operations, including competition, R&D management, and customer relationships [5] - The lawsuit claims that Luminar had no reasonable basis for its financial guidance, and the public statements made by the defendants were materially false and misleading [5]

Group 1 - A shareholder has filed a class action lawsuit on behalf of purchasers of Fluor Corporation securities between February 18, 2025, and July 31, 2025 [1] - Fluor Corporation is described as a company that provides engineering, procurement, and construction (EPC), fabrication and modularization, and project management services worldwide [1]

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Fly-E Group, Inc. securities, alleging that the company provided misleading statements regarding the safety of its lithium battery, which negatively impacted its E-vehicle sales revenue during the class period from July 15, 2025, to August 14, 2025 [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Fly-E Group made overwhelmingly positive statements while concealing material adverse facts about its lithium battery safety, leading to a decline in sales and increased operating expenses [5]. - Investors who purchased Fly-E securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the class action by visiting the provided link or contacting Phillip Kim, Esq. for more information [3][6]. - A lead plaintiff must file a motion with the court by November 10, 2025, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has recovered hundreds of millions of dollars for investors and has been consistently ranked among the top firms in securities class action settlements [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Replimune Group, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Replimune securities class action is from November 22, 2024, to July 21, 2025 [1]. - Investors who purchased Replimune securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must file a motion with the Court by September 22, 2025, to represent other class members in the litigation [3]. Group 2: Case Background - The lawsuit alleges that defendants made materially false and misleading statements regarding the IGNYTE trial, which the FDA deemed inadequate and not well-controlled [5]. - The misleading statements resulted in investors suffering damages when the true details about Replimune's business and operations were revealed [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of V.F. Corporation securities, alleging that the company disseminated materially false and misleading statements regarding its turnaround plans, particularly concerning the Vans brand [1][5]. Group 1: Lawsuit Details - The class action lawsuit pertains to securities purchased between October 30, 2023, and May 20, 2025, inclusive [1]. - The lawsuit claims that V.F. Corporation concealed necessary actions that would impact the revenue growth trajectory of the Vans brand, leading to investor damages when the true information was revealed [5]. Group 2: Participation Information - Investors who purchased V.F. Corporation securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm directly [3][6]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Quantum Corporation securities between November 15, 2024, and August 18, 2025, about the upcoming lead plaintiff deadline of November 3, 2025, in a securities class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Quantum Corporation securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm or visiting their website [3][6] - The lawsuit alleges that Quantum Corporation made false or misleading statements regarding its revenue recognition and will need to restate its financial statements for the fiscal third quarter ended December 31, 2024 [5] Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in recovering hundreds of millions for investors [4] - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and securing over $438 million for investors in 2019 [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Lockheed Martin securities between January 23, 2024, and July 21, 2025, of the upcoming lead plaintiff deadline on September 26, 2025, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Lockheed Martin securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm or visiting their website [3][6]. - The lead plaintiff must file a motion with the Court by September 26, 2025, to represent other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Lockheed Martin made false and misleading statements regarding its internal controls, contract commitments, and risk management practices, which led to significant investor losses when the truth was revealed [5]. - Specific claims include the lack of effective internal controls, inaccurate program reviews, and overstated delivery capabilities, all of which contributed to misleading positive statements about the company's business prospects [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Capricor Therapeutics, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on September 15, 2025 [1] Group 1: Class Action Details - Investors who purchased Capricor securities between October 9, 2024, and July 10, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by September 15, 2025 [3] - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6] Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting their own achievements in this area [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4] - Rosen Law Firm has been recognized for its performance in securities class action settlements, being ranked No. 1 by ISS Securities Class Action Services in 2017 [4] Group 3: Case Specifics - The lawsuit alleges that Capricor provided misleading information regarding its lead cell therapy candidate, deramiocel, which is intended for treating cardiomyopathy associated with Duchenne muscular dystrophy [5] - Defendants allegedly made positive statements about obtaining a Biologics License Application from the FDA while concealing adverse facts about the drug's safety and efficacy data from its Phase 2 trial [5] - The misleading information is claimed to have led to shareholders purchasing securities at inflated prices, resulting in damages when the truth was revealed [5]